JP2009513700A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009513700A5 JP2009513700A5 JP2008538915A JP2008538915A JP2009513700A5 JP 2009513700 A5 JP2009513700 A5 JP 2009513700A5 JP 2008538915 A JP2008538915 A JP 2008538915A JP 2008538915 A JP2008538915 A JP 2008538915A JP 2009513700 A5 JP2009513700 A5 JP 2009513700A5
- Authority
- JP
- Japan
- Prior art keywords
- saturated
- alkyl
- partially unsaturated
- heteroaryl
- alkenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73203705P | 2005-11-01 | 2005-11-01 | |
| US60/732,037 | 2005-11-01 | ||
| PCT/US2006/041251 WO2007053345A1 (en) | 2005-11-01 | 2006-10-24 | Glucokinase activators |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009513700A JP2009513700A (ja) | 2009-04-02 |
| JP2009513700A5 true JP2009513700A5 (enExample) | 2009-10-22 |
| JP5137207B2 JP5137207B2 (ja) | 2013-02-06 |
Family
ID=37685330
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008538915A Expired - Fee Related JP5137207B2 (ja) | 2005-11-01 | 2006-10-24 | グルコキナーゼ活性化因子 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8933077B2 (enExample) |
| EP (1) | EP1948652B1 (enExample) |
| JP (1) | JP5137207B2 (enExample) |
| AT (1) | ATE521608T1 (enExample) |
| AU (1) | AU2006309173B2 (enExample) |
| CA (1) | CA2628274A1 (enExample) |
| ES (1) | ES2372540T3 (enExample) |
| NZ (1) | NZ567858A (enExample) |
| WO (1) | WO2007053345A1 (enExample) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1785420A1 (en) * | 2005-11-14 | 2007-05-16 | 4Sc Ag | Thiazole analogues and uses thereof |
| JP2010500300A (ja) | 2006-08-08 | 2010-01-07 | サノフィ−アベンティス | アリールアミノアリール−アルキル−置換イミダゾリジン−２，４−ジオン、それらの製造法、それらの化合物を含有する薬剤、およびそれらの使用 |
| JP5450108B2 (ja) * | 2007-03-23 | 2014-03-26 | アレイ バイオファーマ、インコーポレイテッド | グルコキナーゼ活性化剤としての２−アミノピリジン類似体 |
| WO2009022179A2 (en) * | 2007-08-14 | 2009-02-19 | Astrazeneca Ab | Glucokinase activators in the treatment of osteoarthritis |
| EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| EA019104B1 (ru) * | 2007-09-21 | 2014-01-30 | Эррей Биофарма Инк. | Активаторы глюкокиназы |
| KR20100090250A (ko) | 2007-10-09 | 2010-08-13 | 메르크 파텐트 게엠베하 | 글루코키나제 활성체로서 유용한 피리딘 유도체 |
| RU2450001C2 (ru) | 2007-12-20 | 2012-05-10 | Эл Джи Лайф Сайенсиз Лтд. | Активаторы глюкокиназы и фармацевтические композиции, содержащие их в качестве активного ингредиента |
| WO2010003624A2 (en) | 2008-07-09 | 2010-01-14 | Sanofi-Aventis | Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
| WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
| JP2012520845A (ja) * | 2009-03-17 | 2012-09-10 | グラクソ グループ リミテッド | Ｉｔｋ阻害剤として使用されるピリミジン誘導体 |
| EP2451817B1 (en) * | 2009-07-10 | 2013-09-04 | Bayer Intellectual Property GmbH | Indazolyl-substituted dihydroisoxa-zolopyridines and methods of use thereof |
| SG178880A1 (en) | 2009-08-26 | 2012-04-27 | Sanofi Sa | Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use |
| WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
| CA2800498C (en) | 2010-03-31 | 2021-11-16 | The Scripps Research Institute | Reprogramming cells |
| EP2582709B1 (de) | 2010-06-18 | 2018-01-24 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
| US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
| TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
| TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
| TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
| WO2012120055A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| WO2012120054A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| EP2683704B1 (de) | 2011-03-08 | 2014-12-17 | Sanofi | Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| EP2766349B1 (de) | 2011-03-08 | 2016-06-01 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| WO2012120056A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| KR20140051834A (ko) | 2011-03-09 | 2014-05-02 | 다이이찌 산쿄 가부시키가이샤 | 디피리딜아민 유도체 |
| WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| EP2760862B1 (en) | 2011-09-27 | 2015-10-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| EP2804605A4 (en) * | 2012-01-20 | 2015-07-08 | Acucela Inc | SUBSTITUTED HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASES |
| EP2850057A4 (en) | 2012-05-18 | 2016-01-27 | Amgen Inc | PROCESS FOR THE PREPARATION OF THIADIAZOLENE |
| WO2019084529A1 (en) * | 2017-10-29 | 2019-05-02 | China Medical University | ADAM9 INHIBITORS AND USES THEREOF |
| BR112021002207A2 (pt) | 2018-08-10 | 2021-05-04 | Diapin Therapeutics, Llc | tri-peptídeos e tratamento de distúrbios metabólicos, cardiovasculares e inflamatórios |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6596476B1 (en) * | 1989-12-22 | 2003-07-22 | Abbott Laboratories | Hepatitis C assay |
| US7125875B2 (en) * | 1999-04-15 | 2006-10-24 | Bristol-Myers Squibb Company | Cyclic protein tyrosine kinase inhibitors |
| CA2366932C (en) | 1999-04-15 | 2009-08-25 | Bristol-Myers Squibb Company | Cyclic protein tyrosine kinase inhibitors |
| MXPA02002559A (es) * | 1999-09-10 | 2002-07-30 | Merck & Co Inc | Inhibidores de tirosina cinasa. |
| BR0116493A (pt) * | 2000-12-21 | 2003-09-30 | Vertex Pharma | Compostos de pirazol úteis como inibidores de proteìna cinase |
| GB0226931D0 (en) * | 2002-11-19 | 2002-12-24 | Astrazeneca Ab | Chemical compounds |
| BRPI0407283A (pt) * | 2003-02-13 | 2006-01-31 | Banyu Pharma Co Ltd | Composto, composição farmacêutica, e, agente ativador de glucoquinase, agentes terapêuticos e/ou agentes preventivos para diabetes melito e obesidade |
| AU2005223610B2 (en) * | 2004-03-23 | 2008-05-29 | Banyu Pharmaceutical Co., Ltd. | Substituted quinazoline or pyridopyrimidine derivative |
-
2006
- 2006-10-24 EP EP06826456A patent/EP1948652B1/en active Active
- 2006-10-24 JP JP2008538915A patent/JP5137207B2/ja not_active Expired - Fee Related
- 2006-10-24 AU AU2006309173A patent/AU2006309173B2/en not_active Ceased
- 2006-10-24 US US12/092,233 patent/US8933077B2/en not_active Expired - Fee Related
- 2006-10-24 AT AT06826456T patent/ATE521608T1/de not_active IP Right Cessation
- 2006-10-24 ES ES06826456T patent/ES2372540T3/es active Active
- 2006-10-24 CA CA002628274A patent/CA2628274A1/en not_active Abandoned
- 2006-10-24 WO PCT/US2006/041251 patent/WO2007053345A1/en not_active Ceased
- 2006-10-24 NZ NZ567858A patent/NZ567858A/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2917267C (en) | Cyanotriazole compounds | |
| EP2247586B1 (en) | 2-aza-bicyclo[2.2.1]heptane derivatives | |
| AU2007351498B2 (en) | Organic compounds | |
| KR101178747B1 (ko) | 프로톤 펌프 저해제 | |
| CN102171204B (zh) | 8位取代异喹啉衍生物及其用途 | |
| JP5702392B2 (ja) | キサンチンオキシダーゼ阻害剤として効果的な新規化合物、その製造方法及びそれを含有する医薬組成物 | |
| JP5040656B2 (ja) | トリアリールカルボン酸誘導体 | |
| PT1910348T (pt) | Compostos de benzotiazol e azabenzotiazol úteis como inibidores de quinases | |
| JP2009524670A5 (enExample) | ||
| BG107284A (bg) | Заместени пиролопиридинонови производни полезни като инхибитори на фосфодиестераза | |
| JP2015503529A5 (enExample) | ||
| CZ20023199A3 (cs) | Modulátory receptoru adenosinu | |
| CN103124730A (zh) | 杂环炔苯类化合物及其药用组合物和应用 | |
| TW200819443A (en) | An imidazole derivative | |
| CN109153649A (zh) | 烟碱乙酰胆碱受体的变构调节剂 | |
| WO1999061436A1 (en) | Heterocyclic indole derivatives and mono- or diazaindole derivatives | |
| JP6559699B2 (ja) | 置換含窒素複素環誘導体、それを含む医薬組成物及びその抗腫瘍性の適用 | |
| FR2911139A1 (fr) | Nouveaux derives de phenyl-(4-phenyl-pyrimidin-2-yl)amines, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk | |
| KR20200081436A (ko) | 파르네소이드 x 수용체 조정제로서의 알켄 화합물 | |
| CA2251681A1 (en) | Aminoisoquinolines and aminothienopyridine derivatives and their use as anti-inflammatory agents | |
| JP7563780B2 (ja) | 心筋細胞増殖活性を有する心臓病治療のための新規な複素環式誘導体 | |
| KR20250121546A (ko) | Gpr17 조절제 및 이의 용도 | |
| HRP20040874A2 (en) | Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders | |
| JP2001506666A (ja) | イミダゾピリダジン | |
| EP2058306A1 (en) | Heteroaryl-substituted 2-pyridinyl-methylamine derivatives |